Short Term Risk of Bilateral Internal Mammary Artery Grafting in Diabetic Patients.

This study compares the morbidity and mortality at 30 days following the use of bilateral internal mammary arteries (BIMA) versus a single internal mammary artery (SIMA) at the time of coronary artery bypass grafting (CABG) in patients with a pre-operative HbA1c. Patients undergoing CABG from January 2008 to December 2016 reported to the Society of Thoracic Surgeons database were retrospectively reviewed. The patients were divided into two groups: use of BIMA or use of SIMA and propensity matched. To assess the effect of preoperative HbA1c, both groups were further divided into 5 sub-groups: patients without diabetes mellitus (DM), or patients with diabetes mellitus and a preoperative HbA1c level in one of four groups (< 7%, 7-9%, 9-11%, or > 11%). The post-operative outcomes in both the BIMA and SIMA groups were compared. There were 700,504 and 28,115 patients with measured pre-operative HbA1c levels in the SIMA and BIMA groups, respectively. Propensity score matching identified 23,635 comparable patients in each group for analysis. There was no difference in postoperative mortality between the BIMA and SIMA groups (1.3% vs 1.2%). The incidences of sternal wound infection (SWI) in patients undergoing placement of BIMA versus SIMA were: 0.8% vs 0.4% with no DM (p<0.0001), 1.9% vs 1.0% with HbA1c < 7% (p<0.001), 2.4% vs 1.2% with HbA1c 7-9% (p<0.001), 2.8% vs 1.4% with HbA1c 9-11% (p=0.02), 4.1% vs 1.5% with HbA1c > 11% (p=0.01). Based on the incidence of SWI, BIMA is a reasonable approach with an HbA1c<7%.

[1]  G. Whitman,et al.  Increased Glucose Variability Is Associated With Major Adverse Events After Coronary Artery Bypass. , 2019, The Annals of thoracic surgery.

[2]  J. Pepper,et al.  Bilateral versus Single Internal‐Thoracic‐Artery Grafts at 10 Years , 2019, The New England journal of medicine.

[3]  R. Habib,et al.  Incremental Value of Increasing Number of Arterial Grafts: The Effect of Diabetes Mellitus. , 2018, The Annals of thoracic surgery.

[4]  S. Verma,et al.  Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. , 2017, Journal of the American College of Cardiology.

[5]  D. Taggart,et al.  Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis , 2017, Heart.

[6]  G. Bisleri,et al.  Improved Outcomes of Total Arterial Myocardial Revascularization in Elderly Patients at Long-Term Follow-Up: A Propensity-Matched Analysis. , 2017, The Annals of thoracic surgery.

[7]  F. Gaita,et al.  Three Arterial Grafts Improve Late Survival: A Meta-Analysis of Propensity-Matched Studies. , 2017, Circulation.

[8]  D. Altman,et al.  Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial. , 2016, The Journal of thoracic and cardiovascular surgery.

[9]  M. Czerny,et al.  Risk Factors for Sternal Wound Infection After Open Heart Operations Vary According to Type of Operation. , 2016, The Annals of thoracic surgery.

[10]  E. Blackstone,et al.  Coronary artery bypass grafting in diabetics: A growing health care cost crisis. , 2015, The Journal of thoracic and cardiovascular surgery.

[11]  M. Mack,et al.  Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. , 2014, European heart journal.

[12]  P. Serruys,et al.  Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2014, Circulation.

[13]  V. Novack,et al.  Increased Glycemic Variability in Patients with Elevated Preoperative HbA1C Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting Surgery , 2014, Anesthesia and analgesia.

[14]  G. Dangas,et al.  Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[15]  D. Altman,et al.  Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). , 2010, European heart journal.

[16]  P. Kurlansky,et al.  Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. , 2010, The Annals of thoracic surgery.

[17]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[18]  R. Shemin,et al.  The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. , 2009, The Annals of thoracic surgery.

[19]  R. Guyton,et al.  Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. , 2008, The Annals of thoracic surgery.

[20]  R. Guyton,et al.  Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  E. Pektok,et al.  Does harvesting of an internal thoracic artery with an ultrasonic scalpel have an effect on sternal perfusion? , 2007, The Journal of thoracic and cardiovascular surgery.

[22]  M. Borger,et al.  Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. , 2005, The Journal of thoracic and cardiovascular surgery.

[23]  L. Fish,et al.  Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. , 2003, The American journal of cardiology.

[24]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[25]  B. Medalion,et al.  Decreased sternal vascularity after internal thoracic artery harvesting resolves with time: an assessment with single photon emission computed tomography. , 2002, The Journal of thoracic and cardiovascular surgery.

[26]  M. Carrier,et al.  1992: Effect of internal mammary artery dissection on sternal vascularization. 1993 update. , 1993, The Annals of thoracic surgery.

[27]  A. Albanese,et al.  Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials†. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  P. Serruys,et al.  Cost-Effectiveness of Percutaneous Coronary Intervention with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel or Left Main Coronary Artery Disease: Final Results from the SYNTAX Trial , 2014 .

[29]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[30]  H. Kamiya,et al.  Sternal microcirculation after skeletonized versus pedicled harvesting of the internal thoracic artery: a randomized study. , 2008, The Journal of thoracic and cardiovascular surgery.

[31]  B. Korbmacher,et al.  Change of sternal perfusion following preparation of the internal thoracic artery--a scintigraphical study. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  M. Carrier,et al.  Effect of internal mammary artery dissection on sternal vascularization. , 1992, The Annals of thoracic surgery.

[33]  C. Shriver,et al.  Sternal blood flow after median sternotomy and mobilization of the internal mammary arteries. , 1988, Surgery.